There is however evidence that in IBD patients with active disease, CD73 expression in CD4+ T-cells is associated with a pro-inflammatory Th17-cell phenotype; based on this evidence, CD73 could be therefore used as a marker to monitor disease activity during treatment (45). Here, NT5E is linked to inflammatory bowel disease.